Table 3:
Comparison of percentages of positive surveillance screening for MRSA and VRE before and after the CP policy change.
Before CP were discontinued | After CP were discontinued | P value | ||
---|---|---|---|---|
MRSA Nasal Swabs | % Positive | 4.5% | 4.9% | 0.255 |
n | 11641 | 11543 | ||
VRE Rectal Swabs | % Positive | 31.7% | 22.6% | 0.084 |
n | 1045 | 84 |